Higher-Dose Fluvoxamine Fails for COVID Outpatients
The extensive quest to repurpose a cheap therapy for non-hospitalized COVID patients has once again fallen short, this time using a higher dose of fluvoxamine (Luvox), a selective serotonin reuptake inhibitor (SSRI). In the latest readout from the multi-platform ACTIV-6 trial, time to sustained recovery landed at an identical 10 days whether patients with mild […]
Templating approach stabilizes ‘ideal’ material for alternative solar cells
Researchers have developed a method to stabilise a promising material known as perovskite for cheap solar cells, without compromising its near-perfect performance. The researchers, from the University of Cambridge, used an organic molecule as a ‘template’ to guide perovskite films into the desired phase as they form. Their results are reported in the journal Science. […]